High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hammad Liaquat; Brittney Shupp; Sarina Kapoor; Ayaz Matin

doi:10.12659/AJCR.926475

21 July 2020 : Case report USA

High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Unusual clinical course, Unusual setting of medical care

Hammad Liaquat^1ADEF*, Brittney Shupp^2BCEF, Sarina Kapoor^1CDEF, Ayaz Matin^1ADEF

DOI: 10.12659/AJCR.926475

Am J Case Rep 2020; 21:e926475

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. (A) Contrast-enhanced chest computed tomography (CT) showing bibasilar infiltrates in the lower lung fields and (B) chest x-ray showing nonspecific linear densities in lower lung fields. Both of these images are consistent with COVID-19 pneumonia.

Back to the Article

High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Your Privacy